These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 22360765)
1. The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T J Microencapsul; 2012; 29(3):211-8. PubMed ID: 22360765 [TBL] [Abstract][Full Text] [Related]
2. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
3. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model. Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583 [TBL] [Abstract][Full Text] [Related]
4. Single injection of ONO-1301-loaded PLGA microspheres directly after ischaemia reduces ischaemic damage in rats subjected to middle cerebral artery occlusion. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T J Pharm Pharmacol; 2012 Mar; 64(3):353-9. PubMed ID: 22309267 [TBL] [Abstract][Full Text] [Related]
5. Effect of antioxidants on the stability of ONO-1301, a novel long-acting prostacyclin agonist, loaded in PLGA microspheres. Uchida T; Hazekawa M; Morisaki T; Yoshida M; Sakai Y J Microencapsul; 2013; 30(3):245-56. PubMed ID: 23094609 [TBL] [Abstract][Full Text] [Related]
6. Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats. Obata H; Sakai Y; Ohnishi S; Takeshita S; Mori H; Kodama M; Kangawa K; Aizawa Y; Nagaya N Am J Respir Crit Care Med; 2008 Jan; 177(2):195-201. PubMed ID: 17975203 [TBL] [Abstract][Full Text] [Related]
7. Preparation and in vivo evaluation of thienorphine-loaded PLGA microspheres. Yang Y; Gao Y Pharmazie; 2010 Oct; 65(10):729-32. PubMed ID: 21105573 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats. Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239 [TBL] [Abstract][Full Text] [Related]
9. Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres. Presmanes C; de Miguel L; Espada R; Alvarez C; Morales E; Torrado JJ J Microencapsul; 2011; 28(8):791-8. PubMed ID: 21967461 [TBL] [Abstract][Full Text] [Related]
10. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Doan TV; Couet W; Olivier JC Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
12. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169 [TBL] [Abstract][Full Text] [Related]
13. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters. Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506 [TBL] [Abstract][Full Text] [Related]
14. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere. Park W; Kim D; Kang HC; Bae YH; Na K Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184 [TBL] [Abstract][Full Text] [Related]
15. Effect of Self-healing Encapsulation on the Initial Burst Release from PLGA Microspheres Containing a Long-Acting Prostacyclin Agonist, ONO-1301. Hazekawa M; Kojima H; Haraguchi T; Yoshida M; Uchida T Chem Pharm Bull (Tokyo); 2017; 65(7):653-659. PubMed ID: 28674339 [TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere. Ye L; Fu F; Liu W; Sun K; Li Y; He J; Yu X; Yu P; Tian J Pak J Pharm Sci; 2013 Mar; 26(2):315-22. PubMed ID: 23455202 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
18. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Chaisri W; Ghassemi AH; Hennink WE; Okonogi S Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499 [TBL] [Abstract][Full Text] [Related]
19. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
20. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity. Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]